Cargando…

Complex Particulate Biomaterials as Immunostimulant-Delivery Platforms

The control of infectious diseases is a major current challenge in intensive aquaculture. Most commercial vaccines are based on live attenuated or inactivated pathogens that are usually combined with adjuvants, oil emulsions being as the most widely used for vaccination in aquaculture. Although effe...

Descripción completa

Detalles Bibliográficos
Autores principales: Torrealba, Débora, Seras-Franzoso, Joaquin, Mamat, Uwe, Wilke, Kathleen, Villaverde, Antonio, Roher, Nerea, Garcia-Fruitós, Elena
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5055299/
https://www.ncbi.nlm.nih.gov/pubmed/27716780
http://dx.doi.org/10.1371/journal.pone.0164073
_version_ 1782458744830951424
author Torrealba, Débora
Seras-Franzoso, Joaquin
Mamat, Uwe
Wilke, Kathleen
Villaverde, Antonio
Roher, Nerea
Garcia-Fruitós, Elena
author_facet Torrealba, Débora
Seras-Franzoso, Joaquin
Mamat, Uwe
Wilke, Kathleen
Villaverde, Antonio
Roher, Nerea
Garcia-Fruitós, Elena
author_sort Torrealba, Débora
collection PubMed
description The control of infectious diseases is a major current challenge in intensive aquaculture. Most commercial vaccines are based on live attenuated or inactivated pathogens that are usually combined with adjuvants, oil emulsions being as the most widely used for vaccination in aquaculture. Although effective, the use of these oil emulsions is plagued with important side effects. Thus, the development of alternative safer and cost-effective immunostimulants and adjuvants is highly desirable. Here we have explored the capacity of inclusion bodies produced in bacteria to immunostimulate and protect fish against bacterial infections. Bacterial inclusion bodies are highly stable, non-toxic protein-based biomaterials produced through fully scalable and low-cost bio-production processes. The present study shows that the composition and structured organization of inclusion body components (protein, lipopolysaccharide, peptidoglycan, DNA and RNA) make these protein biomaterials excellent immunomodulators able to generically protect fish against otherwise lethal bacterial challenges. The results obtained in this work provide evidence that their inherent nature makes bacterial inclusion bodies exceptionally attractive as immunostimulants and this opens the door to the future exploration of this biomaterial as an alternative adjuvant for vaccination purposes in veterinary.
format Online
Article
Text
id pubmed-5055299
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-50552992016-10-27 Complex Particulate Biomaterials as Immunostimulant-Delivery Platforms Torrealba, Débora Seras-Franzoso, Joaquin Mamat, Uwe Wilke, Kathleen Villaverde, Antonio Roher, Nerea Garcia-Fruitós, Elena PLoS One Research Article The control of infectious diseases is a major current challenge in intensive aquaculture. Most commercial vaccines are based on live attenuated or inactivated pathogens that are usually combined with adjuvants, oil emulsions being as the most widely used for vaccination in aquaculture. Although effective, the use of these oil emulsions is plagued with important side effects. Thus, the development of alternative safer and cost-effective immunostimulants and adjuvants is highly desirable. Here we have explored the capacity of inclusion bodies produced in bacteria to immunostimulate and protect fish against bacterial infections. Bacterial inclusion bodies are highly stable, non-toxic protein-based biomaterials produced through fully scalable and low-cost bio-production processes. The present study shows that the composition and structured organization of inclusion body components (protein, lipopolysaccharide, peptidoglycan, DNA and RNA) make these protein biomaterials excellent immunomodulators able to generically protect fish against otherwise lethal bacterial challenges. The results obtained in this work provide evidence that their inherent nature makes bacterial inclusion bodies exceptionally attractive as immunostimulants and this opens the door to the future exploration of this biomaterial as an alternative adjuvant for vaccination purposes in veterinary. Public Library of Science 2016-10-07 /pmc/articles/PMC5055299/ /pubmed/27716780 http://dx.doi.org/10.1371/journal.pone.0164073 Text en © 2016 Torrealba et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Torrealba, Débora
Seras-Franzoso, Joaquin
Mamat, Uwe
Wilke, Kathleen
Villaverde, Antonio
Roher, Nerea
Garcia-Fruitós, Elena
Complex Particulate Biomaterials as Immunostimulant-Delivery Platforms
title Complex Particulate Biomaterials as Immunostimulant-Delivery Platforms
title_full Complex Particulate Biomaterials as Immunostimulant-Delivery Platforms
title_fullStr Complex Particulate Biomaterials as Immunostimulant-Delivery Platforms
title_full_unstemmed Complex Particulate Biomaterials as Immunostimulant-Delivery Platforms
title_short Complex Particulate Biomaterials as Immunostimulant-Delivery Platforms
title_sort complex particulate biomaterials as immunostimulant-delivery platforms
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5055299/
https://www.ncbi.nlm.nih.gov/pubmed/27716780
http://dx.doi.org/10.1371/journal.pone.0164073
work_keys_str_mv AT torrealbadebora complexparticulatebiomaterialsasimmunostimulantdeliveryplatforms
AT serasfranzosojoaquin complexparticulatebiomaterialsasimmunostimulantdeliveryplatforms
AT mamatuwe complexparticulatebiomaterialsasimmunostimulantdeliveryplatforms
AT wilkekathleen complexparticulatebiomaterialsasimmunostimulantdeliveryplatforms
AT villaverdeantonio complexparticulatebiomaterialsasimmunostimulantdeliveryplatforms
AT rohernerea complexparticulatebiomaterialsasimmunostimulantdeliveryplatforms
AT garciafruitoselena complexparticulatebiomaterialsasimmunostimulantdeliveryplatforms